The U.S. Centers for Disease Control and Prevention (CDC) has expressed concern over the low uptake of new COVID-19 vaccines, revealing that only 14 percent of American adults have received these shots, which became available in the fall. The CDC emphasized the added protection these vaccines offer in reducing the severity of COVID-19. Surveys suggest that public hesitancy is due to concerns about side effects and insufficient clinical data.
The CDC recommended these vaccines for nearly all Americans based on FDA authorization and approval, primarily relying on animal testing. However, human testing results have been reported for only 50 individuals, and the CDC has not responded to requests for evidence supporting the vaccines’ effectiveness against severe illness.
The agency noted discrepancies in vaccine uptake among different demographic groups, with higher rates among white people and those with insurance. To address these disparities, the CDC is working to eliminate barriers to vaccination, collaborating with community groups and trusted messengers like doctors to build vaccine confidence.
While the CDC acknowledged higher vaccination rates among elderly individuals, who are more vulnerable to severe COVID-19 outcomes, it highlighted that more than two-thirds of older adults have not received updated vaccines, emphasizing the need for added protection.
Criticism has been directed at the CDC for making claims without supporting data, with some doctors and lawmakers expressing concerns about public trust in the agency. Questions about vaccine recommendations and public trust are set to be addressed by CDC Director Dr. Mandy Cohen in a hearing on November 30, according to statements from Rep. Cathy McMorris Rodgers and Rep. Morgan Griffith.